• Citer

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

par Van Cutsem, Eric;Peeters, Marc;Siena, Salvatore;Humblet, Yves;Hendlisz, Alain ;Neyns, Bart;Canon, Jean-Luc;Van Laethem, Jean-Luc ;Maurel, Joan;Richardson, Gary;Wolf, Michael;Amado, Rafael G
Référence Journal of clinical oncology, 25, 13, page (1658-1664)
Publication Publié, 2007-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
Auteur:	Van Cutsem, Eric; Peeters, Marc; Siena, Salvatore; Humblet, Yves; Hendlisz, Alain; Neyns, Bart; Canon, Jean-Luc; Van Laethem, Jean-Luc; Maurel, Joan; Richardson, Gary; Wolf, Michael; Amado, Rafael G
Informations sur la publication:	Journal of clinical oncology, 25, 13, page (1658-1664)
Statut de publication:	Publié, 2007-05
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Antibodies, Monoclonal -- adverse effects -- pharmacology -- therapeutic use
	Antineoplastic Agents -- adverse effects -- pharmacology -- therapeutic use
	Colorectal Neoplasms -- drug therapy -- nursing -- pathology
	Disease-Free Survival
	Female
	Humans
	Immunohistochemistry
	Male
	Middle Aged
	Neoplasm Metastasis
	Receptor, Epidermal Growth Factor -- antagonists & inhibitors -- metabolism
Note générale:	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2006.08.1620
	info:pii/25/13/1658
	info:scp/34147103678
	info:pmid/17470858